Literature DB >> 21048113

Tripartite-motif protein 30 negatively regulates NLRP3 inflammasome activation by modulating reactive oxygen species production.

Yu Hu1, Kairui Mao, Yan Zeng, Shuzhen Chen, Zhiyun Tao, Chen Yang, Shuhui Sun, Xiaodong Wu, Guangxun Meng, Bing Sun.   

Abstract

The NLR family, pyrin domain-containing 3 (NLRP3) inflammasome is critical for caspase-1 activation and the proteolytic processing of pro-IL-1β. However, the mechanism that regulates NLRP3 inflammasome activation remains unclear. In this paper, we demonstrate that tripartite-motif protein 30 (TRIM30) negatively regulates NLRP3 inflammasome activation. After stimulation with ATP, an agonist of the NLRP3 inflammasome, knockdown of TRIM30 enhanced caspase-1 activation and increased production of IL-1β in both J774 cells and bone marrow-derived macrophages. Similarly with ATP, knockdown of TRIM30 increased caspase-1 activation and IL-1β production triggered by other NLRP3 inflammasome agonists, including nigericin, monosodium urate, and silica. Production of reactive oxygen species was increased in TRIM30 knockdown cells, and its increase was required for enhanced NLRP3 inflammasome activation, because antioxidant treatment blocked excess IL-1β production. Conversely, overexpression of TRIM30 attenuated reactive oxygen species production and NLRP3 inflammasome activation. Finally, in a crystal-induced NLRP3 inflammasome-dependent peritonitis model, monosodium urate-induced neutrophil flux and IL-1β production was reduced significantly in TRIM30 transgenic mice as compared with that in their nontransgenic littermates. Taken together, our results indicate that TRIM30 is a negative regulator of NLRP3 inflammasome activation and provide insights into the role of TRIM30 in maintaining inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21048113     DOI: 10.4049/jimmunol.1001099

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Molecular mechanisms regulating NLRP3 inflammasome activation.

Authors:  Eun-Kyeong Jo; Jin Kyung Kim; Dong-Min Shin; Chihiro Sasakawa
Journal:  Cell Mol Immunol       Date:  2015-11-09       Impact factor: 11.530

2.  Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles.

Authors:  Anna C Reisetter; Larissa V Stebounova; Jonas Baltrusaitis; Linda Powers; Amit Gupta; Vicki H Grassian; Martha M Monick
Journal:  J Biol Chem       Date:  2011-04-27       Impact factor: 5.157

3.  Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

Authors:  Caroline Jefferies; Claire Wynne; Rowan Higgs
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

Review 4.  Mechanisms and pathways of innate immune activation and regulation in health and cancer.

Authors:  Jun Cui; Yongjun Chen; Helen Y Wang; Rong-Fu Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 5.  Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.

Authors:  Jin Kyung Kim; Hyo Sun Jin; Hyun-Woo Suh; Eun-Kyeong Jo
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

Review 6.  Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Anu Kauppinen
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 7.  Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity.

Authors:  Akshay A D'Cruz; Jeffrey J Babon; Raymond S Norton; Nicos A Nicola; Sandra E Nicholson
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

8.  Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.

Authors:  Charles S Dela Cruz; Wei Liu; Chuan Hua He; Adam Jacoby; Alex Gornitzky; Bing Ma; Richard Flavell; Chun Geun Lee; Jack A Elias
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

Review 9.  Inflammasomes, the eye and anti-inflammasome therapy.

Authors:  P Yerramothu; A K Vijay; M D P Willcox
Journal:  Eye (Lond)       Date:  2017-11-24       Impact factor: 3.775

10.  Oxidative stress in Mexicans with diffuse cutaneous systemic sclerosis.

Authors:  M P Cruz-Domínguez; D H Montes-Cortes; I M Olivares-Corichi; O Vera-Lastra; G Medina; L J Jara
Journal:  Rheumatol Int       Date:  2013-03-02       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.